Download the case study "Helping a top-10 pharma develop an organoid-based predictive toxicology model"
Complete the form to learn how a top-10 pharma company’s toxicology group leveraged extensive, authoritative data to develop a predictive toxicology model.
As this group looked to shift away from animal testing to more reliable and ethical alternatives, Elsevier combined its data, tools, and expertise to provide a machine-readable custom dataset to inform an organoid-based predictive toxicology model. The dataset consisted of a ranked list of drugs with corresponding information on the reported incidence and severity of the adverse event in question, as well as other details essential to establishing an evidence-based calibration curve for more accurate predictions.
Get access to the full story and let us know if you would like to hear more about Elsevier’s data solutions.